AD	Alzheimer’s disease
ADAS-cog	Alzheimer’s Disease Assessment Scale–Cognitive Subscale
AE	Adverse event
BBB	Blood–brain barrier
CDR-SB	Clinical Dementia Rating–Sum of Boxes
CNS	Central nervous system
CSCs	Cancer stem cells
DCLK1	Doublecortin-like kinase 1
EGFR	Epidermal growth factor receptor
EMT	Epithelial–mesenchymal transition
FDA	Food and Drug Administration
HCV	Hepatitis C virus
IC50	Half-maximal inhibitory concentration
IUPAC	International Union of Pure and Applied Chemistry
JAK	Janus kinase
JNK	c-Jun N-terminal kinase
MAPK	Mitogen-activated protein kinase
MMSE	Mini-Mental State Examination
MMP	Matrix metalloproteinase
mTOR	Mechanistic target of rapamycin
NF-κB	Nuclear factor kappa B
NSCLC	Non-small cell lung cancer
ORR	Objective response rate
PI3K	Phosphoinositide 3-kinase
PRISMA	Preferred Reporting Items for Systematic Reviews and Meta-Analyses
ROS	Reactive oxygen species
RSV	Resveratrol
SAMDC	S-adenosylmethionine decarboxylase
SRT501	Micronized resveratrol formulation
STAT	Signal transducer and activator of transcription
T2DM	Type 2 diabetes mellitus
UGT	Uridine diphosphate-glucuronosyltransferase
SULT	Sulfotransferase
VEGFR2	Vascular endothelial growth factor receptor 2
Wnt	Wingless-related integration site
YAP1	Yes-associated protein 1